Canbi Pharma Tech Limited
1802220-02-5 Repotrectinib

1802220-02-5 Repotrectinib

CAS:1802220-02-5
MF:C18H18FN5O2
MW:355.37
EINECS:125-417-3
MDL No.:MFCD31544350

Send Inquiry
Description

Properties

Appearance White to off-white crystalline solid
Density 1.46±0.1 g/cm3
storage temp. Store at -20°C
form A crystalline solid
pka10.79±0.60
 

Application:

    Repotrectinib, It is an anti-cancer drug used to treat non-small cell lung cancer. Repotrectinib is an inhibitor of oncogene tyrosine protein kinase ROS1 (ROS1) and tropomyosin receptor tyrosine kinase (TRK) TRKA, TRKB, and TRKC.

 

Synonyms:

Repotrectinib

1802220-02-5

Ropotrectinib

repotrectinibum

(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one

TRX-0005

1,15-Etheno-1H-pyrazolo(4,3-F)(1,4,8,10)benzoxatriazacyclotridecin-4(5H)-one, 11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-, (7S,13R)-

(13E,14E,3R,6S)-45-fluoro-3,6-dimethyl-5-oxa-2,8-diaza-1(5,3)-pyrazolo[1,5-a]pyrimidina-4(1,2)-benzenacyclononaphan-9-one

(1Z)-6-Fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentaazatetracyclo(13.5.2.04,9.018,22)docosa-1,4,6,8,15,19,21-heptaen-14-one

1,15-Etheno-1H-pyrazolo(4,3-f)(1,4,8,10)benzoxatriazacyclotridecin-4(5H)-one, 11-fluoro-2,6,7,13-tetrahydro-7,13-dimethyl-, (14Z)-

example 93 (US20170334929A1)

(7S,13R)-11-Fluoro-7,13-Dimethyl-6,7,13,14-Tetrahydro-1,15-Ethenopyrazolo[4,3-F][1,4,8,10]Benzoxatriazacyclotridecin-4(5H)-One

 

Hot Tags: 1802220-02-5 repotrectinib, China 1802220-02-5 repotrectinib manufacturers, suppliers, api shipping and handling api integration, api small business api integration, api prescriptive analytics api integration, api business intelligence api integration, api xml format, Vitamin D2

Inquiry
goTop

(0/10)

clearall